Matches in Wikidata for { <http://www.wikidata.org/entity/Q90761441> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q90761441 description "article scientifique publié en 2020" @default.
- Q90761441 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q90761441 description "im Januar 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90761441 description "scientific article published on 07 January 2020" @default.
- Q90761441 description "wetenschappelijk artikel" @default.
- Q90761441 description "наукова стаття, опублікована 7 січня 2020" @default.
- Q90761441 name "Ixekizumab Results in Persistent Clinical Improvement in Moderate-to-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial" @default.
- Q90761441 name "Ixekizumab Results in Persistent Clinical Improvement in Moderate-to-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial" @default.
- Q90761441 type Item @default.
- Q90761441 label "Ixekizumab Results in Persistent Clinical Improvement in Moderate-to-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial" @default.
- Q90761441 label "Ixekizumab Results in Persistent Clinical Improvement in Moderate-to-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial" @default.
- Q90761441 prefLabel "Ixekizumab Results in Persistent Clinical Improvement in Moderate-to-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial" @default.
- Q90761441 prefLabel "Ixekizumab Results in Persistent Clinical Improvement in Moderate-to-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial" @default.
- Q90761441 P1433 Q90761441-03D7886F-9BBD-4C05-BD5C-81274C2B6F50 @default.
- Q90761441 P1476 Q90761441-5817919F-82A4-4841-8520-F3AFD659563A @default.
- Q90761441 P2093 Q90761441-6AE0C053-FC25-41C9-988A-EE4AC1C5DA8A @default.
- Q90761441 P2093 Q90761441-85E4DDA1-4576-465C-BF13-9AAC32BC6EEE @default.
- Q90761441 P2093 Q90761441-91D57030-DF19-4B4E-B33E-E1676C5F5ED6 @default.
- Q90761441 P2093 Q90761441-93D4DD25-8B0B-4D40-9D43-BE0990E6F344 @default.
- Q90761441 P2093 Q90761441-AA6FD364-D4B2-44FF-8FEE-9EF2DB353D00 @default.
- Q90761441 P2093 Q90761441-AD511154-C043-4A80-9EB9-DAA1F7D24384 @default.
- Q90761441 P2093 Q90761441-C7DE6C63-C87A-4B2D-BDA7-78E53EEAF0C3 @default.
- Q90761441 P2093 Q90761441-ECFB9AB1-FB95-4D17-A0D7-58EAAAC62090 @default.
- Q90761441 P2093 Q90761441-FE660D9E-9C43-4B57-9DF1-B993C5D0CFB7 @default.
- Q90761441 P2093 Q90761441-FF14DB55-0675-4526-9E30-7A9031DED37A @default.
- Q90761441 P304 Q90761441-6AB4DEBF-158F-48DA-AA13-9316C89E3E0A @default.
- Q90761441 P31 Q90761441-A9AE1A51-4558-40B3-A3D4-F6D650EA0393 @default.
- Q90761441 P356 Q90761441-380ABF2E-5DD4-4EF1-86F0-4874BB15AF13 @default.
- Q90761441 P433 Q90761441-D1DCFE82-725A-413B-B8DF-7E0584C776CE @default.
- Q90761441 P478 Q90761441-32BC01C7-381E-4261-8380-A23850273A2B @default.
- Q90761441 P577 Q90761441-45D745C7-157D-4716-B38E-86A5BD28DFD4 @default.
- Q90761441 P698 Q90761441-8ACC4CB3-51D0-4CA9-BBC4-441ED41929A0 @default.
- Q90761441 P921 Q90761441-26DC9CAA-B661-4DE4-A30F-D6EE50775788 @default.
- Q90761441 P921 Q90761441-C95F809D-A170-4A56-BB22-4A96EA7E6CA3 @default.
- Q90761441 P921 Q90761441-ba323e24-4e35-bb35-ff54-80d3e2f6cf17 @default.
- Q90761441 P356 00015555-3353 @default.
- Q90761441 P698 31620802 @default.
- Q90761441 P1433 Q18326503 @default.
- Q90761441 P1476 "Ixekizumab Results in Persistent Clinical Improvement in Moderate-to-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial" @default.
- Q90761441 P2093 "Alison Potts Bleakman" @default.
- Q90761441 P2093 "Caitriona Ryan" @default.
- Q90761441 P2093 "Clinton C Bertram" @default.
- Q90761441 P2093 "Jamie Weisman" @default.
- Q90761441 P2093 "Janelle Erickson" @default.
- Q90761441 P2093 "Kristin Todd" @default.
- Q90761441 P2093 "Lyn Guenther" @default.
- Q90761441 P2093 "Lynda Spelman" @default.
- Q90761441 P2093 "Russel Burge" @default.
- Q90761441 P2093 "Yves Poulin" @default.
- Q90761441 P304 "adv00006" @default.
- Q90761441 P31 Q13442814 @default.
- Q90761441 P356 "10.2340/00015555-3353" @default.
- Q90761441 P433 "1" @default.
- Q90761441 P478 "100" @default.
- Q90761441 P577 "2020-01-07T00:00:00Z" @default.
- Q90761441 P698 "31620802" @default.
- Q90761441 P921 Q13574436 @default.
- Q90761441 P921 Q269829 @default.
- Q90761441 P921 Q42824827 @default.